This topic contains a solution. Click here to go to the answer

Author Question: A patient is brought to the emergency department after poisoning with unknown agents and is ... (Read 41 times)

evelyn o bentley

  • Hero Member
  • *****
  • Posts: 564
A patient is brought to the emergency department after poisoning with unknown agents and is comatose. A component of therapy will likely be:
 
  1. intravenous flumazenil.
  2. syrup of ipecac.
  3. activated charcoal.
  4. intravenous dextrose.

Question 2

A patient who takes warfarin 5 mg/day reports using an herbal product. Which herbal product (s) would be of the most concern? You may select more than one answer.
 
  1. Ephedrine
  2. Ginkgo biloba
  3. Feverfew
  4. Garlic
  5. Ginger



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ashley I

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

Correct Answer: 4

Answer to Question 2

Correct Answers: 2, 3, 4




evelyn o bentley

  • Member
  • Posts: 564
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


softEldritch

  • Member
  • Posts: 334
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library